genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
Synthetic Data for a Real Pandemic
Gene Therapy
Bayer Approach to Partnerships, Pipelines, and Platforms
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
Circulating Tumor Cell
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Biomarkers
Guardant Health Launches Early-Stage Colorectal Cancer ctDNA Assay
News
Neuroscience
Dopamine Circuit Responsible for Temporary Memory Loss
OMICs
Skin Cell Atlas Uncovers Origin of Inflammatory Skin Disease
Animal Models
CRISPR-Based Cancer Cell Lineage Tracing Offers Insights into Drivers of Metastasis
Drug Discovery
Hormonal Coupling Identified That Incites Inflammatory Rage and Ages the Brain
Antisense
Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Biopharma Manufacturers Shouldn’t Rush When “Going Digital”
Bioprocessing
Separating Cells with Microfluidics
Trends for 2021
Beyond 2021: Cell Therapy Manufacturing Trends
Bioprocessing
Machine Learning for Better Bioprocess Data Analysis
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
OMICs
Skin Cell Atlas Uncovers Origin of Inflammatory Skin Disease
Animal Models
CRISPR-Based Cancer Cell Lineage Tracing Offers Insights into Drivers of Metastasis
Drug Discovery
Hormonal Coupling Identified That Incites Inflammatory Rage and Ages the Brain
Antisense
Antisense Oligo Targets IRF4 Gene to Treat Multiple Myeloma
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Cancer
Renal Cancer
Renal Cancer
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Renal Cancer
Promising Triple Therapy Approach Identified for Renal Cell Carcinoma
Renal Cancer
Researchers Discover Key Structures in Kidney Formation
Renal Cancer
Merck & Co. to Acquire Peloton for Up to $2.2B, Adding Late-Stage Kidney Cancer Candidate
Renal Cancer
Merck & Co., Eisai Launch Up-to-$5.76B Cancer Partnership
Renal Cancer
Cancer Research UK, Biotecnol to Advance Solid Tumor Immunotherapy into the Clinic
Renal Cancer
Acceleron Halts Development of Cancer Candidate Dalantercept
Renal Cancer
New Mouse Model Developed for Investigating Kidney Cancer
Renal Cancer
Immunotherapy Advanced by Immune Cell Studies of Lung and Kidney Cancers
Renal Cancer
Argos Says Lead Candidate Likely to Fail Phase III Trial
Renal Cancer
After RCC Trial Failure, Cerulean to Slash Headcount
Renal Cancer
AVEO Oncology Awards European Rights to Tivozanib for Up to $396.5M+
Renal Cancer
GSK, Idera Partner on Third-Gen Antisense Drugs for Renal Disease
Renal Cancer
AstraZeneca, Isis Pharma Expand Antisense Collaboration
Renal Cancer
FDA Rejects Aveo’s Tivozanib for RCC; Rips Phase III Results
Renal Cancer
Pfizer Drug Disappoints in Treatment-Naive RCC Study
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
